AU2001275487A1 - Regulation of the p21 gene and uses thereof - Google Patents
Regulation of the p21 gene and uses thereofInfo
- Publication number
- AU2001275487A1 AU2001275487A1 AU2001275487A AU7548701A AU2001275487A1 AU 2001275487 A1 AU2001275487 A1 AU 2001275487A1 AU 2001275487 A AU2001275487 A AU 2001275487A AU 7548701 A AU7548701 A AU 7548701A AU 2001275487 A1 AU2001275487 A1 AU 2001275487A1
- Authority
- AU
- Australia
- Prior art keywords
- gene
- regulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21222400P | 2000-06-16 | 2000-06-16 | |
US60212224 | 2000-06-16 | ||
PCT/US2001/019107 WO2001098775A1 (en) | 2000-06-16 | 2001-06-14 | Regulation of the p21 gene and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001275487A1 true AU2001275487A1 (en) | 2002-01-02 |
Family
ID=22790099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001275487A Abandoned AU2001275487A1 (en) | 2000-06-16 | 2001-06-14 | Regulation of the p21 gene and uses thereof |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020107171A1 (en) |
AU (1) | AU2001275487A1 (en) |
WO (1) | WO2001098775A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8674095B2 (en) | 2008-12-19 | 2014-03-18 | Afraxis Holdings, Inc. | Compounds for treating neuropsychiatric conditions |
US8372970B2 (en) * | 2009-10-09 | 2013-02-12 | Afraxis, Inc. | 8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5863904A (en) * | 1995-09-26 | 1999-01-26 | The University Of Michigan | Methods for treating cancers and restenosis with P21 |
-
2001
- 2001-06-14 US US09/881,635 patent/US20020107171A1/en not_active Abandoned
- 2001-06-14 AU AU2001275487A patent/AU2001275487A1/en not_active Abandoned
- 2001-06-14 WO PCT/US2001/019107 patent/WO2001098775A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20020107171A1 (en) | 2002-08-08 |
WO2001098775A1 (en) | 2001-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002366803A1 (en) | Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor | |
AU2002315389A1 (en) | Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof | |
AU2002253836A1 (en) | Aptamer-mediated regulation of gene expression | |
AU2002329759A1 (en) | Methyltransferase genes and uses thereof | |
AU2002315388A1 (en) | Novel phenylamino-pyrimidines and uses thereof | |
AU2088801A (en) | Metastasis genes and uses thereof | |
AU3072500A (en) | Rhamnosyl-transferase gene and uses thereof | |
AU2001269077A1 (en) | Methods and means for regulation of gene expression | |
AU2002319460A1 (en) | Improvement of gene expression in vectors | |
AU2002302247A1 (en) | Genes and proteins involved in the biosynthesis of enediyne ring structures | |
AU2001275487A1 (en) | Regulation of the p21 gene and uses thereof | |
AU1894601A (en) | Novel gene and use thereof | |
AU2001252062A1 (en) | Steatosis-modulating factors and uses thereof | |
AU5617200A (en) | Nodavirus-based dna expression vector and uses thereof | |
AU2002213398A1 (en) | Expression vectors and uses thereof | |
AU2003277537A1 (en) | REGULATION OF INTERACTION BETWEEN RAPL AND Rap1 | |
AU2002214970A1 (en) | The m30 gene family and the utilization thereof | |
AU2001259228A1 (en) | Pancreatic progenitor 1 gene and its uses | |
AU2001282132A1 (en) | Isolation and sequencing of the pknb gene of c. glutamicum | |
AU2002240921A1 (en) | Medane genes and proteins | |
AU2001253386A1 (en) | Haplotypes of the impdh2 gene | |
AU3976900A (en) | Combination of p53 gene and e1b-deleted p53 gene | |
AU2001261708A1 (en) | Pharmacokinetics-algorithms for controlling and regulating the consumption of various drugs | |
AU5033101A (en) | Regulation of human heparanase-like enzyme | |
AU2002352698A1 (en) | Immune-related proteins and the regulation of the same |